Candel Therapeutics, Inc. short interest in 2021

In 2021, Candel Therapeutics, Inc.'s disclosed short interest ran from 0.21% of shares outstanding on 31 Aug 2021 to 0.19% on 31 Dec 2021, a change of -0.02 percentage points. The year's high was 0.48% on 15 Sep 2021 and its low 0.13% on 15 Dec 2021, averaging 0.24% across 9 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.33 days on 29 Oct 2021. Full history: Candel Therapeutics, Inc..

Cite this page

Plain

Short position data for Candel Therapeutics, Inc. short interest in 2021: FINRA, compiled by howshorted.com, settlement date 31 Dec 2021. https://howshorted.com/us/company/cadl/2021/

Wikipedia

<ref>{{cite web |title=Candel Therapeutics, Inc. short interest in 2021 short position data |url=https://howshorted.com/us/company/cadl/2021/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2021-12-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-candel-therapeutics-inc-short-interest-i-2021-12-31,
  title        = {Candel Therapeutics, Inc. short interest in 2021 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/cadl/2021/}},
  note         = {Data: FINRA, settlement date 31 Dec 2021; accessed 2026-10-13},
  year         = {2021}
}

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

2021 in figures

Start of year: 0.21% (31 Aug 2021)
End of year: 0.19% (31 Dec 2021)
Change: -0.02 pp
High: 0.48% (15 Sep 2021)
Low: 0.13% (15 Dec 2021)
Average: 0.24%
Highest days to cover: 2.33 (29 Oct 2021)
SEC filings marked: 4

Every report in 2021

Candel Therapeutics, Inc. short interest in 2021
Settlement	Short interest	Days to cover	Filings since previous
31 Aug 2021	0.21%	1.00
15 Sep 2021	0.48%	1.00	10-Q filed, results (8-K)
30 Sep 2021	0.32%	1.00
15 Oct 2021	0.23%	1.88
29 Oct 2021	0.27%	2.33
15 Nov 2021	0.17%	1.61	10-Q filed, results (8-K)
30 Nov 2021	0.15%	1.00
15 Dec 2021	0.13%	1.00
31 Dec 2021	0.19%	1.00

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.